D-0923-2017 Class III Terminated
FDA drug recall D-0923-2017 was initiated by Noven Pharmaceuticals, Inc. on Apr 27, 2017 and is designated Class III. Reason for recall: Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH. The recall status is terminated (terminated Mar 11, 2019). Affected quantity: 14434 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 5, 2017
- Initiation Date
- Apr 27, 2017
- Termination Date
- Mar 11, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14434 cartons
Product description
Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8
Reason for recall
Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.
Distribution pattern
Nationwide within US
Code information
Lot #:: 78618, Exp. 05/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0923-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026